Skip to main content

Life Science Instrumentation Market Size [2021-2028] | Growth, Share, Industry Trends Forecast

Life Science Instrumentation Market to Benefit from the Increasing Awareness Regarding Early Diagnosis and Treatment | Fortune Business Insights

Pune, India, March 21, 2022 (GLOBE NEWSWIRE) — The global life science instrumentation market will benefit from recent advancements in the life science instrumentation industry. According to a report by Fortune Business Insights, titled “Life Science Instrumentation Market Size, Share and Global Trend By Technology (PCR, Spectroscopy, Microscopy, Chromatography, Electrophoresis, Next-generation sequencing (NGS), Flow Cytometry, Centrifuges), By Application (Clinical and Diagnostic, Research), By Distribution Channel (Hospitals and diagnostic laboratories, Pharmaceutical and biotechnology companies, Academic & Research institutions) and Geography Forecast till 2026,” the market will grow considerably in the coming years due to the increasing prevalence of chronic conditions.


Request Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/life-science-instrumentation-market-101036


The increased prevalence of chronic conditions in developed as well as developing nations has created the demand for life science instrumentation. The severity of chronic diseases, combined with the need for early diagnosis and treatment will aid the growth of the global life science instrumentation market in the coming years. Furthermore, the increased awareness regarding early detection and treatment of chronic diseases will contribute to the demand for life science instrumentation across the world. Fortune Business Insights has included several factors that have contributed to the growth of the global market in recent years. Additionally, the report provides forecast values for the market through extensive research analysis methods.

Life science Instrumentation Industry Will Derive Growth from New Products

The increased patient pool for chronic diseases and other severe diseases has created the demand for efficient treatment and diagnosis methods. Life science instrumentation has provided the answer to the growing patient needs, which in turn, has aided the growth of the companies operating in this market. Encouraged by the high demand, companies are focused on introducing new products and incorporating latest technologies in order to suffice the increased consumer needs. Among the several life science instrumentation market growth stimulators, Fortune Business Insights has labelled the increasing number of product launches as one of the leading factors accounting for market growth. In February 2019, Tecan announced the launch of a new product aimed at enhancing the overall operation of library preparation kits. Tecan’s NGS DreamPrep will significantly reduce the total time required for preparing libraries and also help increase the accuracy and efficiency of test results. Fortune Business Insights has predicted that Tecan’s latest product will help the company generate substantial life science instrumentation market revenue in the coming years, and subsequently aid growth of the global market.


Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/life-science-instrumentation-market-101036


North America Likely to Emerge as One of the Leading Regions

The growing adoption of advanced product launches and the trends of modern technologies has opened the doors for rapid growth of the life science instrumentation market in North America. The report explains in detail, the reasons behind North America’s recent market dominance. Similarly, the report provides segmentation of the global life science instrumentation market based on regional demographics and categorizes the market in major regions such as Asia Pacific, Middle East and Africa, Latin America, and Europe. Fortune Business Insights, through its extensive research analysis techniques, predicts that the life science instrumentation market in Asia Pacific will grow at the highest CAGR in the coming years, among all regions.

Fortune Business Insights has profiled a few of the leading life science instrumentation market companies of recent times. Some of the prominent companies that have held significant market share include Danaher, Thermo Fisher Scientific, Inc., Merck & Co., Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., BD, Bruker, and Hitachi High-Technologies Corporation.


Inquire Before Buying: https://www.fortunebusinessinsights.com/enquiry/queries/life-science-instrumentation-market-101036


Table of Content:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1. Key Industry Developments – Merger, Acquisitions, and Partnerships

4.2. Porter’s Five Forces Analysis

4.3. SWOT Analysis

4.4. Technological Developments

4.5. Value Chain Analysis

4.6. Impact of COVID-19 on Life Science Instrumentation Market

5. Global Life Science Instrumentation Market Analysis, Insights and Forecast, 2017-2028

5.1. Key Findings / Summary

Continued…

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

 
Contact Us:

Fortune Business Insights™ Pvt. Ltd.

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.